S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Buy THIS stock before Taiwan is attacked (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Buy THIS stock before Taiwan is attacked (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Buy THIS stock before Taiwan is attacked (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Buy THIS stock before Taiwan is attacked (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Buy THIS stock before Taiwan is attacked (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Buy THIS stock before Taiwan is attacked (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Buy THIS stock before Taiwan is attacked (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Buy THIS stock before Taiwan is attacked (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Buy THIS stock before Taiwan is attacked (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Buy THIS stock before Taiwan is attacked (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Buy THIS stock before Taiwan is attacked (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Buy THIS stock before Taiwan is attacked (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
NASDAQ:AVGR

Avinger - AVGR Stock Forecast, Price & News

$0.82
0.00 (0.00%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.82
$0.83
50-Day Range
$0.81
$1.53
52-Week Range
$0.80
$3.92
Volume
20,893 shs
Average Volume
61,171 shs
Market Capitalization
$8.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Avinger MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
1,000.2% Upside
$9.00 Price Target
Short Interest
Healthy
0.74% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.01mentions of Avinger in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$181 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.50 out of 5 stars


AVGR stock logo

About Avinger (NASDAQ:AVGR) Stock

Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.

Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Stock News Headlines

Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com
StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)
The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
Contrasting Avinger (NASDAQ:AVGR) & Motus GI (NASDAQ:MOTS)
Avinger Reports Fourth Quarter 2022 Results
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Avinger Announces 510(k) Filing of Pantheris LV
Avinger Reports Third Quarter 2022 Results
Avinger to Present at LD Micro Investor Conference
Avinger, Inc. (AVGR)
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Company Calendar

Last Earnings
11/11/2021
Today
3/25/2023
Next Earnings (Estimated)
5/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVGR
Employees
68
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.00
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+1,000.2%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-17,620,000.00
Net Margins
-213.02%
Pretax Margin
-213.02%

Debt

Sales & Book Value

Annual Sales
$8.27 million
Book Value
$0.56 per share

Miscellaneous

Free Float
10,034,000
Market Cap
$8.25 million
Optionable
Not Optionable
Beta
1.52

Key Executives

  • Jeffrey M. Soinski
    President, Chief Executive Officer & Director
  • Nabeel Subainati
    Chief Financial & Accounting Officer
  • Himanshu N. Patel
    Chief Technology Officer
  • Jaafer Golzar
    Chief Medical Officer
  • Philip R. Preuss
    Vice President-Marketing & Business Operations













AVGR Stock - Frequently Asked Questions

What is Avinger's stock price forecast for 2023?

0 brokerages have issued twelve-month price objectives for Avinger's shares. Their AVGR share price forecasts range from $9.00 to $9.00. On average, they expect the company's stock price to reach $9.00 in the next year. This suggests a possible upside of 1,000.2% from the stock's current price.
View analysts price targets for AVGR
or view top-rated stocks among Wall Street analysts.

How have AVGR shares performed in 2023?

Avinger's stock was trading at $1.0850 at the beginning of the year. Since then, AVGR shares have decreased by 24.6% and is now trading at $0.8180.
View the best growth stocks for 2023 here
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) posted its earnings results on Thursday, November, 11th. The medical device company reported ($1.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.40) by $0.20. The medical device company earned $2.37 million during the quarter, compared to the consensus estimate of $2.52 million. Avinger had a negative net margin of 213.02% and a negative trailing twelve-month return on equity of 286.05%. During the same period in the prior year, the firm earned ($1.60) earnings per share.

When did Avinger's stock split?

Avinger shares reverse split on the morning of Tuesday, March 15th 2022. The 1-20 reverse split was announced on Tuesday, March 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Who are Avinger's major shareholders?

Avinger's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Armistice Capital LLC (9.68%). Insiders that own company stock include Himanshu Patel, James Cullen, Jeffrey M Soinski, Mark Weinswig and Nabeel Paul Subainati.
View institutional ownership trends
.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.82.

How much money does Avinger make?

Avinger (NASDAQ:AVGR) has a market capitalization of $8.25 million and generates $8.27 million in revenue each year. The medical device company earns $-17,620,000.00 in net income (profit) each year or ($4.74) on an earnings per share basis.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The official website for the company is www.avinger.com. The medical device company can be reached via phone at (650) 241-7900, via email at info@dawson3d.com, or via fax at 800-229-2696.

This page (NASDAQ:AVGR) was last updated on 3/25/2023 by MarketBeat.com Staff